ACCESS AFP REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS
FDA premarket approval P980041/S021 · decided 2013-02-06
Approval details
- PMA number
- P980041
- Supplement
- S021
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- ACCESS AFP REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS
- Generic name
- KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
- Applicant
- Beckman Coulter, Inc.
- Date received
- 2013-01-03
- Decision date
- 2013-02-06
- Days to decision
- 34 days
- Decision code
- OK30
- Product code
- LOK
- Advisory committee
- Immunology
- Expedited review
- No
- Location
- Brea, CA
- Statement
- CHANGE TO THE SPECIAL CLEAN MAINTENANCE PROCEDURE THAT MITIGATES VITAMIN B 12 CARRYOVER FROM A WASH BUFFER/ METHANOL COMBINATION TO A METHANOL/DI COMBINATION AND ALSO TO USE ETHANOL AND METHANOL INTERCHANGEABLY AS PART OF THE SPECIAL CLEAN MAINTENANCE PROCEDURE. THIS SPECIAL CLEAN PROCEDURE WOULD BE USED WITH THE ACCESS AFP, HYBRITECH FREE PSA,HYBRITECH PSA AND HYBRITECH P2PSA REAGENTS ON THE ACCESS, ACCESS 2, SYNCHRON LXI 725, AND UNICEL DXC 600I INTEGRATED CLINICAL SYSTEMS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| Access BNP II (K252169) | Beckman Coulter, Inc. | 2026-03-24 |
| Access anti-HBc IgM (K254059) | Beckman Coulter, Inc. | 2026-03-13 |
| Access anti-HBc Total (K253687) | Beckman Coulter, Inc. | 2026-02-19 |
| Access anti-HAV IgM (K251995) | Beckman Coulter, Inc. | 2026-01-27 |
| Access Rubella IgG (K250588) | Beckman Coulter, Inc. | 2025-11-17 |
| iQ200 Series (K252580) | Beckman Coulter, Inc. | 2025-09-10 |
| Access anti-HAV (K243846) | Beckman Coulter, Inc. | 2025-09-09 |
| MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan) (K243804) | Beckman Coulter, Inc. | 2025-08-20 |